[1]Buemi M, Cavallaro E, Floccari F, et al. Erythropoietin and the brain: from neurodevelopment to neuroprotection[J].Clin Sci,2002,103(3):275-282.
[2]Davis JM, Arakawa T, Strickland TW, et al. Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells[J].Biochemistry,1987,26(9):2633-2638.
[3]Browne JK,Cohen AM, Egrie JC, et al. Erythropoietin: gene cloning, protein structure, and biological properties[J]. Cold Spring Harb Symp Quant Biol,1986, 1(51):693-702.
[4]Choi D, Kim M, Park J. Erythropoietin:physico-and biochemical analysis[J].J Chromatogr B Biomed Appl, 1996,687(1):189-199.
[5]Eid T, Brines M. Recombinant human erythropoietin for neuroprotection: what is the evidence? [J].Clin Breast Cancer,2002,3(3):109-115.
[6]Obara N, Imagawa S, Nakano Y, et al.Suppression of erythropoietin gene expression by cadmium depends on inhibition of HIF-1, not stimulation of GATA-2 [J].Arch Toxicol,2003,77(5):267-273.
[7]Chen YH,Comeaux LM,Evles SJ, et al. Auto-hydroxylation of FIH-1: an Fe(ii),alpha-ketoglutarate-dependent human hypoxia sensor[J]. Chem Commun,2008,21(39):4768-4770.
[8]Youssoufian H, Lodish HF. Transcriptional inhibition of the murine erythropoietin receptor gene by an upstream repetitive element[J]. Mol Cell Biol, 1993,13(1):98-104.
[9]Wu Y, Shang Y, Sun S, et al. Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3b/caspase-3 mediated signaling pathway[J].Apoptosis,2007,12(8):1365-1375.
[10]Sola A, Wen TC, Hamrick SE,et al. Potential for protection and repair following injury to the developing brain: a role for erythropoietin? [J]. Pediatr Res,2005,57(5):110-117.
[11]Sola A, Rogido M, Lee BH, et al. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats [J].Pediatr Res,2005,57(4):481-487.
[12]Chen X,Chen Y,Bi Y,et al. Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy [J].Cardiovasc Drugs Ther, 2007,21(5):367-374.
[13]Ribeil JA,Zermati Y,Vandekerckhove J,et al. Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1[J].Nature, 2007, 445(7123):102-105.
[14]Goldsmith MA, Mikami A, You Y, et al. Absence of cytokine receptor-dependent specificity in red blood cell differentiation in vivo [J].Proc Natl Acad Sci USA,1998,95(12):7006-7011.
[15]Sun Y, Calvert JW, Zhang JH. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration[J].Stroke,2005,36(8):1672-1678.
[16]Villa P, Bigini P,Mennini T,et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal a poptosis[J].Exp Med,2003,198(6):971-975.
[17]Villa P, van Beek J, Larsen AK, et al. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives[J].Cereb Blood Flow Metab,2007,27(3):552-563.
[18]Hirose S,Takahashi M,Ogawa R,et al. Erythropoietin attenuates the development of experimental autoimmune myocarditis[J].Cardiovasc Drugs Ther,2007,21(1):17-27.
[19]Zhang F, Signore AP, Zhou Z, et al. Erythropoietin protects CA1 neurons against global cerebral ischemia in rat:potential signaling mechanisms[J].Neurosci Res, 2006,83(7):1241-1251.
[20]Zhang F, Wang S, Cao G, et al. Signaltransducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia[J].Neurobiol Dis,2007,25(1):45-53.
[21]Shang Y, Wu Y, Yao S,et al.Protective effect of erythropoietin against ketamine-induced apoptosis in cultured rat cortical neurons: Involvement of PI3K/Akt and GSK-3 beta pathway[J].Apoptosis, 2007,12(12):2187-2195.
[22]d′Uscio LV, Katusic ZS. Erythropoietin increases endothelial biosynthesis of tetrahydrobiopterin by activation of protein kinase B alpha/Akt1[J].Hypertension, 2008,52(1):93-99.
[23]Culmsee C, Siewe J,Junker V,et al. Reciprocal inhibition of p53 and nuclearfactor-kappa B transcriptional activities determines cell survival or deathin neurons[J].Neurosci,2003,23(24):8586-8595.
[24]Chen G, Shi JX, Hang CH, et al.Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model:a potential neuroprotective mechanism of recombinant human erythropoietin(rhEPO)[J].Neuroscience Letters,2007,425(3):177-182.
[25]Hirose S,Takahashi M,Ogawa R,et al. Erythropoietin attenuates the development of experimental autoimmune myocarditis[J].Cardiovasc Drugs Ther,2007,21(1):17-27.
[26]Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts[J].Genes Dev,1999,13(22):2905-2927.
[27]Subramanian A, Heqde S, Correll PH,et al.Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility[J].Leuk Res, 2006,30(9):1141-1149.
[28]Wrighton NC, Farrell FX, Chang R, et al. Small peptides as potent mimetics of the protein hormone erythropoietin[J].Science,1996,273(5274):458-464.
[29]Fiordaliso F,Chimenti S,Staszewsky L,et al.A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury[J].Proc Natl Acad Sci USA, 2005,102(6):2046-2051.
[30]Leist M, Ghezzi P, Grasso G,et al.Derivatives of erythropoietin that are tissue protective but not erythropoietic[J].Science,2004,305(5681):239-242. |